I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fujimoto, Nobukazu
196
results:
Search for persons
X
Format
Online (196)
Mediatypes
Articles (Online) (120)
Bookchapter (Online) (1)
OpenAccess-fulltext (75)
Sorted by: Relevance
Sorted by: Year
?
1
Impacts of probiotics on the efficacies of immune checkpoin..:
Morita, Ayako
;
Ichihara, Eiki
;
Inoue, Koji
...
International Journal of Cancer. 154 (2024) 9 - p. 1607-1615 , 2024
Link:
https://doi.org/10.1002/..
?
2
A single arm Phase I/II trial on the combination of carbopl..:
Nogami, Naoyuki
;
Kubo, Toshio
;
Bessho, Akihiro
...
Japanese Journal of Clinical Oncology. 54 (2024) 7 - p. 805-812 , 2024
Link:
https://doi.org/10.1093/..
?
3
Clinical characteristics of patients treated with immune ch..:
Kuribayashi, Tadahiro
;
Ohashi, Kadoaki
;
Nishii, Kazuya
...
Journal of Cancer Research and Clinical Oncology. 150 (2024) 2 - p. , 2024
Link:
https://doi.org/10.1007/..
?
4
Randomized phase II study of daily versus alternate-day adm..:
Yamamoto, Hiromasa
;
Soh, Junichi
;
Okumura, Norihito
...
PLOS ONE. 18 (2023) 5 - p. e0285273 , 2023
Link:
https://doi.org/10.1371/..
?
5
Nationwide prospective registry database of patients with n..:
Hasegawa, Seiki
;
Shintani, Yasushi
;
Takuwa, Teruhisa
...
Cancer Science. 115 (2023) 2 - p. 507-528 , 2023
Link:
https://doi.org/10.1111/..
?
6
A phase II study of S-1 and cisplatin with concurrent thora..:
Tanaka, Hisashi
;
Tanzawa, Shigeru
;
Misumi, Toshihiro
...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211427 , 2022
Link:
https://doi.org/10.1177/..
?
7
Thrombocytopenia as an Immune-Related Adverse Event in Mali..:
Tanaka, Takaaki
;
Asakura, Shoji
;
Hisamatsu, Kazuya
.
JTO Clinical and Research Reports. 3 (2022) 7 - p. 100351 , 2022
Link:
https://doi.org/10.1016/..
?
8
Boerhaave syndrome presenting black pleural effusion: A cas..:
Tanaka, Takaaki
;
Ikeuchi, Ryosuke
;
Hisamatsu, Kazuya
...
Respiratory Medicine Case Reports. 40 (2022) - p. 101781 , 2022
Link:
https://doi.org/10.1016/..
?
9
First and repeat rebiopsy for detecting EGFR T790M mutation..:
Kudo, Kenichiro
;
Nishii, Kazuya
;
Makimoto, Go
...
Journal of Cancer Research and Clinical Oncology. 148 (2022) 8 - p. 1869-1877 , 2022
Link:
https://doi.org/10.1007/..
?
10
The Effect of Pleural Effusion on Prognosis in Patients wit..:
Nishimura, Tomoka
;
Ichihara, Eiki
;
Yokoyama, Toshihide
...
Cancers. 14 (2022) 24 - p. 6184 , 2022
Link:
https://doi.org/10.3390/..
?
11
First-line nivolumab plus ipilimumab versus chemotherapy fo..:
Scherpereel, Arnaud
;
Antonia, Scott
;
Bautista, Yolanda
...
Lung Cancer. 167 (2022) - p. 8-16 , 2022
Link:
https://doi.org/10.1016/..
?
12
The role of comprehensive analysis with circulating tumor D..:
Sueoka‐Aragane, Naoko
;
Nakashima, Chiho
;
Yoshida, Hironori
...
Cancer Medicine. 10 (2021) 12 - p. 3873-3885 , 2021
Link:
https://doi.org/10.1002/..
?
13
JME-001 phase II trial of first-line combination chemothera..:
Miyamoto, Yosuke
;
Kozuki, Toshiyuki
;
Aoe, Keisuke
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 10 - p. e003288 , 2021
Link:
https://doi.org/10.1136/..
?
14
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 M..:
Nakagawa, Kazuhiko
;
Kijima, Takashi
;
Okada, Morihito
...
JTO Clinical and Research Reports. 2 (2021) 6 - p. 100178 , 2021
Link:
https://doi.org/10.1016/..
?
15
First-line nivolumab plus ipilimumab in unresectable malign..:
Baas, Paul
;
Scherpereel, Arnaud
;
Nowak, Anna K
...
The Lancet. 397 (2021) 10272 - p. 375-386 , 2021
Link:
https://doi.org/10.1016/..
1-15